Stay updated on CT-P16 vs Avastin in Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the CT-P16 vs Avastin in Lung Cancer Clinical Trial page.

Latest updates to the CT-P16 vs Avastin in Lung Cancer Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe study page now displays a 403 Forbidden message, replacing the usual study details with an access-restricted notice.SummaryDifference17%

- Check38 days agoChange DetectedRevision tag updated from v3.6.5 to v3.6.6, signaling a new platform release. This change does not modify the study details or the information presented on the page.SummaryDifference0.1%

- Check60 days agoChange Detected- Added a new publication citation: Kim T, Kim H, Lee H, Ahn K, Park T, Baek H, Chang MJ. Population Pharmacokinetic Comparability of CT-P16 Versus EU-Avastin(R) and US-Avastin(R) in Healthy Subjects and Patients with Non-Squamous Non-Small Cell Lung Cancer. BioDrugs. 2026 Aug 2. Online ahead of print. - Page revision updated from v3.6.4 to v3.6.5.SummaryDifference0.1%

- Check74 days agoChange DetectedThe page's revision tag was updated from v3.6.3 to v3.6.4. This indicates a small metadata update to the study record.SummaryDifference0.1%

- Check96 days agoChange DetectedThe page’s revision tag was updated from v3.6.2 to v3.6.3. This indicates a minor metadata update rather than changes to study data or displayed content.SummaryDifference0.1%

- Check103 days agoChange DetectedThe page revision label was updated from v3.6.0 to v3.6.2, indicating a newer deployment of the page template. This change does not alter visible content or user-facing features.SummaryDifference0.1%

Stay in the know with updates to CT-P16 vs Avastin in Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CT-P16 vs Avastin in Lung Cancer Clinical Trial page.